Use coupon code “MARCH20” for a 20% discount on all items! Valid until 31-03-2025

Site Logo
Search Suggestions

      Royal Mail  express delivery to UK destinations

      Regular sales and promotions

      Stock updates every 20 minutes!

      Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

      3 in stock

      Firm sale: non returnable item
      SKU 9780443186776 Categories ,
      Select Guide Rating
      Overexpression of receptor tyrosine kinases (RTKs) has been implicated in cancer. Increasing evidence suggests that dysregulation of RTKs is reported in many neurodegenerative and psychiatric disorders. Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorde...

      £121.00

      Buy new:

      Delivery: UK delivery Only. Usually dispatched in 1-2 working days.

      Shipping costs: All shipping costs calculated in the cart or during the checkout process.

      Standard service (normally 2-3 working days): 48hr Tracked service.

      Premium service (next working day): 24hr Tracked service – signature service included.

      Royal mail: 24 & 48hr Tracked: Trackable items weighing up to 20kg are tracked to door and are inclusive of text and email with ‘Leave in Safe Place’ options, but are non-signature services. Examples of service expected: Standard 48hr service – if ordered before 3pm on Thursday then expected delivery would be on Saturday. If Premium 24hr service used, then expected delivery would be Friday.

      Signature Service: This service is only available for tracked items.

      Leave in Safe Place: This option is available at no additional charge for tracked services.

      Description

      Product ID:9780443186776
      Product Form:Paperback / softback
      Country of Manufacture:NL
      Title:Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
      Authors:Author: Aiman Saad and Professor of Pharmacology and Toxicology, Cairo University, Cairo, Egypt) El-Khatib, Mahmoud Mohamed Khattab, Heba Mohamed, PhD , Egyptian Drug Authority (EDA), Egypt.) Mansour
      Page Count:604
      Subjects:Diseases and disorders, Diseases & disorders, Neurology and clinical neurophysiology, Psychiatry, Neurology & clinical neurophysiology, Psychiatry
      Description:Select Guide Rating
      Overexpression of receptor tyrosine kinases (RTKs) has been implicated in cancer. Increasing evidence suggests that dysregulation of RTKs is reported in many neurodegenerative and psychiatric disorders. Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders provides a fundamental, pragmatic map of RTKs structure, activation, functions, mechanism of action, gene regulation, and signaling pathways in developing central nervous system (CNS), adult normal CNS, neurodegenerative and psychiatric disorders. Additionally, the structure, function, activation, and therapeutic potential of many growth factors have been covered. Here, international experts in the field offer a comprehensive discussion of results of pre-clinical and clinical studies of repositioning of anti-cancer receptor tyrosine kinase inhibitors (RTKIs) and other promising protein kinase inhibitors in various neurodegenerative disorders including, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, Huntington's disease, and multiple sclerosis, and psychiatric disorders including, anxiety, depression, alcohol use disorder, and schizophrenia. In addition, the book discusses the obstacles and opportunities for the potential repositioning of kinase inhibitors in neurodegenerative and psychiatric disorders.
      Imprint Name:Academic Press Inc
      Publisher Name:Elsevier Science Publishing Co Inc
      Country of Publication:GB
      Publishing Date:2023-06-08

      Additional information

      Weight1254 g
      Dimensions199 × 242 × 34 mm